ERBB2 and breast carcinoma: Clinically, although evidence in this context is lacking, curcumin, alongside chemotherapy, has been found to reduce the severity of radiation dermatitis in breast cancer patients with noninflammatory invasive disease or carcinoma in situ, without molecular subtype stratification (e.g., ER+, HER2+, TNBC) [67].